Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120906 · ClinicalTrials.gov registry record · NA
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
A NA study of Liver, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07120906 is a NA study of Liver that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 23-participant average among 3 other Liver trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07120906, a NA study of Liver, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the safety and feasibility of using a needle guidance system (LUMENA) create by CLEAR GUIDE MEDICAL for needle placement for biopsy or liver tumor ablation procedures.
Conditions Studied
Interventions
- DEVICE MRI guided procedure software evaluation
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-25 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07120906
The ClinicalTrials.gov registry entry for NCT07120906 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 23-participant average among 3 other Liver trials with a reported enrollment target (57% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver appearing as the primary indexed condition, and to 1 intervention - of which MRI guided procedure software evaluation is the first listed.
NCT07120906 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07120906 about?
NCT07120906 is a clinical study titled "Augmented Reality Real-Time Guidance for MRI-Guided Interventions". The purpose of this research is to evaluate the safety and feasibility of using a needle guidance system (LUMENA) create by CLEAR GUIDE MEDICAL for needle placement for biopsy or liver tumor ablation procedures.
What is the current status of trial NCT07120906?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-07-25. Estimated completion is 2026-12-31.
What conditions does trial NCT07120906 study?
This clinical trial studies the following conditions: Liver.
What interventions are being tested in trial NCT07120906?
The interventions under investigation include: MRI guided procedure software evaluation (DEVICE).
Who is sponsoring clinical trial NCT07120906?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120906 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
RECRUITING · NA
-
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.